SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solana (SOL) is a cryptocurrency launched in 2020. Solana has a current supply of 636,822,022.65079832 with 590,150,211.79771733 in circulation. The last known price of Solana is 94.05303263 USD and is down -1.56 over the last 24 hours. It is currently trading on 1189 active market(s) with $1,556,044,818.54 traded over the last 24 hours. More information can be found at https://solana.com.

Solana

Solana is being discussed amid a broad crypto pullback, with traders citing concerns about a reported major Binance security incident alongside persistent technical weakness. Bearish voices warn of more downside, while others view the dip as a buying opportunity and say they are accumulating or staking SOL.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPengs record October deliveries and sharply higher overseas sales are drawing attention, with traders debating whether the volume growth can translate into better margins and support its Q4 targets. The operational news is met with caution as many point to the stocks prolonged decline, China EV competition and profitability concerns.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons stronger-than-expected Q3 results, led by a surge in refining earnings, and its planned shareholder returns have drawn attention as the stock reached a 52-week high. Traders are debating whether the breakout can continue or the shares look extended after the run-up.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to fresh 52-week highs is drawing attention ahead of its expected Q3 report, with traders focused on whether BRIUMVIs sales momentum and guidance will support the rally. Buyout and short-squeeze theories are adding to the bullish chatter, but neither is confirmed, and some traders warn that expectations may already be elevated.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the FDAs pending decision on Capricors deramiocel for Duchenne muscular dystrophy, with traders weighing the amended application and upper-limb data against the earlier negative AdCom and statistical concerns. Bulls read recent launch hiring and a more flexible rare-disease regulatory climate as encouraging signs, while skeptics stress that neither hiring nor community advocacy guarantees approval.

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,809.831273 with 281,866,746.118905 in circulation. The last known price of OFFICIAL TRUMP is 1.73532194 USD and is up 9.97 over the last 24 hours. It is currently trading on 744 active market(s) with $259,407,006.57 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

Discussion centers on the planned VIP dinner for top TRUMP token holders, which traders view as a possible source of renewed interest; others see the event as another promotion for a highly speculative meme coin. Many posters focus on the tokens steep losses and describe it as a pump-and-dump, while some remain bullish on short-term rebounds.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs upcoming earnings report is the dominant focus, with traders looking for guidance and growth to clear high expectations rather than relying on a beat alone. The pullback and broader weakness in AI and tech stocks have sharpened the debate: bulls expect strong results to support the premium valuation, while bears warn that even solid results could trigger a selloff if guidance disappoints.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is drawing attention amid a sharp pullback alongside other AI and optical-networking stocks, with traders pointing to broader AI-sector selling and concerns about spending, valuation, and further share dilution rather than a confirmed company-specific catalyst. The move has split the community between dip buyers betting on data-center demand and bearish traders worried about continued downside ahead of earnings.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gileads stronger-than-expected quarterly results, raised product-sales outlook and continued HIV-franchise growth are driving attention as shares reach fresh highs. Traders are broadly positive on the results, while some interpret put-heavy options activity as possible profit-taking or a hedge after the run-up.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, E-Vapor Products and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The E-Vapor Products segment contracts with third-party importers to supply all of its products and sells its e-vapor products to customers in the United States. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altrias third-quarter report beat expectations, lifted its full-year outlook and expanded its buyback, drawing attention as shares approached record highs. Traders welcomed the earnings and shareholder-return news, while some remained cautious about declining cigarette volumes and the sustainability of the rally.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3

Equity

Ark Invest increased its exposure to several widely followed biotechnology stocks during the session.

HOOD Stock Heads For Worst Month Since February: Cathie Wood's ARK Loads Up Amid Dip

ARK Investment Management purchased stock worth $9.1 million across three exchange-traded funds on Wednesday. 

Cathie Wood’s ARK Scoops Up 2 Brazilian Stocks Amid Selloff On Lula’s Win; Michael Burry Sees ‘Opportunity’ In One

Following a sharp selloff in Brazilian stocks after election results, ARK Investment Management purchased shares worth $964.8K in Nu Holdings and shares of MercadoLibre worth $3.7 million across two of its exchange-traded funds.

Cathie Wood-Led Ark Invest Sells PLTR, GOOG, SHOP Stocks — But Loads Up On PACB, FRNM And Other Biotech Firms

Ark Invest reduced its exposure to several widely followed technology stocks during the session.

Cathie Wood's ARK Loads Up 38,110 Meta Shares Across 3 ETFs Despite Mounting AI Spending Concerns

ARK's purchases came as Meta stock fell nearly 7% on Thursday, with investors weighing strong advertising growth and early Muse adoption against rising AI infrastructure costs.

Netflix's Higher Spending Fails To Lift Engagement, Says Wolfe In Downgrade — But Argus Still Sees 46% Upside Potential

Cathie Wood's ARK Invest purchased 18,783 Netflix shares through its ARK Next Generation Internet ETF on Wednesday, according to trading disclosures.

SPOT Stock Hits 10-Month High Despite Q3 Earnings Miss: Co-CEO Says Spotify ‘Is Now An Agent,’ Brushes Off AI Churn Fears

Spotify added 6 million premium subscribers in the third quarter, bringing the total to 306 million and beating its guidance.


Are Concerns Over CoreWeave's Debt Overblown? ETFs in Focus

Concerns over CoreWeave's debt may be overblown, while optimism about its business model persists. Explore ETFs offering exposure to the AI computing firm.

CRWV Stock Dips Overnight: Cathie Wood's ARK Investment Loads Up On Neocloud Despite Recent Market Selloff

Cathie Wood's ARK Investment purchased 132,498 shares of CoreWeave across two ETFs on Monday despite a recent selloff in the company. 

Circle CEO Seeks ‘The Happy Middle’ For USDC As BIS Finds Deposit Rates Weigh More On USDC Than Tether 

Cryptocurrency

Higher Fed rates also push banks to provide better deposit rates, which may slow adoption of stablecoins as users weigh their options.


ARK ETF Trust - ARK Next Generation Technology ETF

Bullish Sentiment

<ul class="summary-bullets"><li>ARK's actively managed ETFs made a mix of moves, trimming some established holdings while adding to smaller healthcare names.</li><li>ARK Genomic Revolution ETF increased its exposure to Tempus AI, Pacific Biosciences of California, Beam Therapeutics, and Arcturus Therapeutics.</li><li>Eli Lilly was among ARK’s notable trims on Friday, with its flagship ARK Innovation ETF paring its position despite Lilly’s blowout third-quarter performance.</li></ul>Cathie Wood’s ARK Invest made a series of moves across its actively managed ETFs on Friday, with the firm adding to several healthcare, genomics and cryptocurrency stocks.ARK's actively managed ETFs made a mix of moves, trimming some established holdings while adding to smaller healthcare names. Several stocks appeared in more than one fund.<h2 class="st-heading-2">ARK Loads Up On Biotech Stocks</h2>Tempus AI Inc. (TEM) was one of ARK’s more prominent biotech-related purchases. ARK added 61,114 shares through ARK Genomic Revolution ETF (ARKG) and another 93,407 shares through ARK Innovation ETF (ARKK), increasing its exposure to the AI-powered healthcare and genomics company across two funds.Illumina Inc. (ILMN) was another significant addition, with ARKK buying 43,130 shares of the genomics sequencing company.ARKG also added to several other biotechnology names, buying 133,767 shares of Pacific Biosciences of California Inc. (PACB), 22,687 shares of Beam Therapeutics Inc. (BEAM) and 64,483 shares of Arcturus Therapeutics Holdings Inc. (ARCT). ARKK separately bought another 346,507 shares of Pacific Biosciences.Outside healthcare and genomics, ARK added to Circle Internet Group Inc. (CRCL) and Coinbase Global Inc. (COIN) across multiple ETFs. ARK Blockchain &amp; Fintech Innovation ETF (ARKF) also bought 13,757 shares of Robinhood Markets Inc. (HOOD).<h2 class="st-heading-2">ARK’s Surprise Sell</h2>Eli Lilly &amp; Co. (LLY) was among the notable positions ARK pared on Friday. ARK’s flagship ARKK ETF sold 17,626 shares of the pharmaceutical giant.The move came after Lilly reported third-quarter results that topped expectations, with the company continuing to benefit from strong demand for its diabetes and obesity medicines.ARK also reduced its exposure to CareDx Inc. (CDNA), with the ARKG ETF selling 50,859 shares.Bullish (BLSH) was another recurring sell. ARK sold shares of the crypto-focused financial services company through ARKF, ARKK and ARKW, with the trades totaling more than 238,000 shares across the three ETFs.<a href="https://stocktwits.com/symbol/ARKG">ARKG’s price</a> fell nearly 7% in Friday’s regular trading session. Retail sentiment on Stocktwits around ARKG trended in the ‘bullish’ territory at the time of writing.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/l3-harris-ba-report-record-backlogs-hii-raises-shipbuilding-revenue/cZUKNB8R9cf">Stocktwits Defense Watch: L3Harris, BA Report Record Backlogs, HII Raises FY2026 Shipbuilding Revenue Forecast</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cathie Wood, Founder & CEO, Ark Invest, speaks during the second day of the FII PRIORITY Summit held at the Faena Hotel on February 20, 2025 in Miami Beach, Florida. (Photo by Joe Raedle/Getty Images)

Arcturus Therapeutics Holdings Inc

ARK Fintech Innovation ETF

ARK Investment Management LLC - ARK Genomic Revolution ETF

ARK Innovation ETF

ARK Next Generation Internet ETF

Beam Therapeutics Inc

Caredx Inc

Coinbase Global Inc

Circle

Robinhood Markets Inc

Illumina Inc

Lilly(Eli) & Co

Pacific Biosciences of California Inc

Tempus AI Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$147.02
Prev Close	$155.16
Open	$149.55
Dividend Yield	N/A
50-Day Moving Average	$158.87
Beta	N/A
Avg. Volume	57,416.67
PE Ratio	N/A

52-Week High	$177.52
52-Week Low	$113.36
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

ARKW Fundamentals